---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-180042"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2022-06-23T23:59:59+00:00"
generated_at: "2026-06-24T23:47:28.255269+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Teva shareholders approve amendments to Articles of Association and elect four directors at annual meeting

## Summary
- Shareholders approved amendments to Articles, effective June 23, 2022, including eliminating minimum in-person board meetings and allowing chairman discretion on meetings in Israel.
- Four directors elected: Amir Elstein, Roberto A. Mignone, Dr. Perry D. Nisen, Dr. Tal Zaks, each to serve until 2025 annual meeting.
- Non-binding advisory vote on executive compensation approved with 424.6M for vs 137.8M against.
- Appointment of Kesselman & Kesselman (PwC) as independent auditor approved.

## SEC filing metadata
- accession: 0001193125-22-180042
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2022-06-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312522180042/0001193125-22-180042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312522180042/d730888d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-180042
- JSON: https://secwatch.observer/filing/0001193125-22-180042.json
- Plain text: https://secwatch.observer/filing/0001193125-22-180042.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.